Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Proliferative Diabetic Retinopathy”

96 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 96 results

Not applicableUnknownNCT04808804
What this trial is testing

Retinal Neurodegeneration In Type 2 Diabetes Mellitus Detected by Optical Coherence Tomography

Who this might be right for
Retinal NeuropathyNeurodegeneration
Assiut University 80
Testing effectiveness (Phase 2)UnknownNCT05007262
What this trial is testing

Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy

Who this might be right for
Type2 DiabetesDiabetic Retinopathy
Guizhou Bailing Group Pharmaceutical Co Ltd 240
Not applicableUnknownNCT01790945
What this trial is testing

Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography

Who this might be right for
Mild Nonproliferative Diabetic RetinopathyModerate Nonproliferative Diabetic RetinopathySevere Nonproliferative Diabetic Retinopathy+2 more
Retina Institute of Hawaii 500
Testing effectiveness (Phase 2)UnknownNCT04782128
What this trial is testing

Evaluation of RC28-E Injection in Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
RemeGen Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT04552600
What this trial is testing

Study to Evaluate Clinical Efficacy and Safety of Nuvastatic™ - C5OSEW5050ESA in Diabetic Retinopathy.

Who this might be right for
Diabetic Retinopathy
Natureceuticals Sdn Bhd 100
Not applicableStudy completedNCT04636307
What this trial is testing

Characterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures (CHART)

Who this might be right for
NPDR - Non Proliferative Diabetic RetinopathyDiabetes Mellitus, Type 2Retinal Disease
Association for Innovation and Biomedical Research on Light and Image 202
Testing effectiveness (Phase 2)Ended earlyNCT02681809
What this trial is testing

Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR

Who this might be right for
Diabetic RetinopathyPosterior Vitreous DetachmentDisease Progression
ThromboGenics 48
Testing effectiveness (Phase 2)Study completedNCT01724554
What this trial is testing

Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion

Who this might be right for
Central Retinal Vein OcclusionProliferative Diabetic Retinopathy
Ophthalmic Consultants of Boston 24
Not applicableEnded earlyNCT03242031
What this trial is testing

Medico-economic Comparison Between Treatment with Panretinal Photocoagulation by Laser in 1 Session Versus 4 Sessions in Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Centre Hospitalier Universitaire Dijon 48
Large-scale testing (Phase 3)Study completedNCT01872611
What this trial is testing

Nepafenac Once Daily for Macular Edema - Study 2

Who this might be right for
Non-Proliferative Diabetic RetinopathyCataract
Alcon Research 819
Post-approval studies (Phase 4)Study completedNCT03962296
What this trial is testing

A Multicenter, Randomized, Double-blind Non-inferiority Trial to Evaluate the Efficacy and Safety of Entelon®

Who this might be right for
Diabetic Retinopathy
Hanyang University 153
Large-scale testing (Phase 3)Looking for participantsNCT04661358
What this trial is testing

Fenofibrate for Prevention of DR Worsening

Who this might be right for
Diabetic Retinopathy
Jaeb Center for Health Research 560
Very early researchNot Yet RecruitingNCT07198815
What this trial is testing

A Preliminary Exploratory Clinical Trial to Evaluate the Efficacy of NPDR-01 Eye Drops in the Treatment of Non-Proliferative Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy (NPDR)Diabetic Retinal MicroangiopathyRetinal Microaneurysms+1 more
Sichuan Academy of Medical Sciences 10
Early research (Phase 1)Study completedNCT06487845
What this trial is testing

Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Participants

Who this might be right for
Chronic Kidney DiseaseNon-proliferative Diabetic RetinopathyHealthy Volunteers
Bayer 24
Large-scale testing (Phase 3)UnknownNCT00908778
What this trial is testing

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Who this might be right for
Diabetic Retinopathy
Vitreoretinal Technologies, Inc. 160
Testing effectiveness (Phase 2)Study completedNCT06599684
What this trial is testing

Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy

Who this might be right for
Non-center Involved Diabetic Macular EdemaNon-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic RetinopathyDiabetic Retinopathy+2 more
Invirsa, Inc. 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT05681884
What this trial is testing

Safety and Efficacy of Faricimab in Patients With NPDR

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Greater Houston Retina Research 179
Testing effectiveness (Phase 2)Active Not RecruitingNCT05393284
What this trial is testing

Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy
Valo Health, Inc. 114
Post-approval studies (Phase 4)Study completedNCT07230184
What this trial is testing

To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR

Who this might be right for
Non-Proliferative Diabetic Retinopathy
AJU Pharm Co., Ltd. 52
Large-scale testing (Phase 3)Study completedNCT02718326
What this trial is testing

Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
Regeneron Pharmaceuticals 402
Load More Results